Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Cancer

Explore clinical trials studying Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

1,289 public trials 285 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Cancer trial results

Active, Not Recruiting

NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer

NCT06094140

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • GenesisCare North Shore Sydney, New South Wales, Australia
  • Wollongong Hospital Wollongong, New South Wales, Australia
  • Warringal Private Hospital Melbourne, Victoria, Australia
View Trial Details
Active, Not Recruiting

Predicting Effective Therapy in Pancreatic Cancer

NCT03033927

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • Memorial Sloan Kettering Cancer Center Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
  • Memorial Sloan Kettering Nassau Uniondale, New York, United States
View Trial Details
Active, Not Recruiting

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

NCT05945823

Conditions
Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +22 more
Locations
  • University of California Los Angeles UCLA - Cancer Care - Santa Monica Santa Monica, California, United States
  • Rocky Mountain Cancer Centers Midtown Denver, Colorado, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

9-ING-41 in Patients With Advanced Cancers

NCT03678883

Conditions
Acute T Cell Leukemia Lymphoma, Bone Cancer, Bone Diseases, +90 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California Irvine Health Orange, California, United States
View all 66 locations
View Trial Details
Active, Not Recruiting

A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer

NCT05984602

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • Ambulatory Care Center New York, United States
  • Clinical Cancer Center New York, United States
  • NYU Langone Ambulatory Care Center East 38th Street New York, United States
View Trial Details

Related conditions